CytoSorbents presentation at OneMedForum San Francisco 2012; $CTSO
CytoSorbents Corporation (OTCBB: CTSO) is a critical care-focused therapeutic device company using blood purification to treat life-threatening illnesses. Its purification technology is based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and adsorption. In March 2011, CytoSorb™, the Company's flagship product, achieved European regulatory approval as an extracorporeal cytokine filter, and can now be sold throughout the European Union (E.U.) under the CE Mark to be used in cases where cytokines are elevated. The company presented at the One Med Forum in San Francisco, which ran from January 9 through 12th, 2012. Company CEO Dr. Phillip Chan gave the presentation included below.